Impact on Neurodegenerative Diseases

Neurodegenerative disorders are amongst the leading causes of worldwide disability, morbidity and decreased quality of life. They are increasingly associated with the concomitant worldwide epidemic of obesity. Although the prevalence of both AD and PD continue to rise, the available treatment strategies to combat these conditions remain ineffective against an increase in global neurodegenerative risk factors.

Obesity is associated with several pathologies including neuropathies and the ability of the nervous system to repair following injury. While further research is needed in characterizing the nature of the effect of obesity on the nervous system, there are current studies suggesting that such effects can be modified.

  • Linking Autism to Obesity
  • Neurological Disorders & Child Obesity
  • AgRP Neurons Regulation & Obesity
  • Pediatric Anorexia Nervosa and Treatment
  • Gut-Microbiota-Brain Axis and Child Obesity
  • Body Mass Index and Eating Disorder Psychopathology
  • Depression and Cognitive Function in Overweight Toddlers
  • Obesity Linking Progressive & Aging-Related Neurodegenerative Diseases
  • Neuromodulation Treatments for Eating Disorders
  • Brain Imaging & Childhood Obesity
  • Brain Malformations & Paediatric Diabetes
  • ADHD & Overweight Children

Related Conference of Impact on Neurodegenerative Diseases

July 17-18, 2017

11th Obesity and Endocrinology Congress

Melbourne, Australia
August 23-24, 2017

12th World Congress on Obesity, Bariatric & Metabolic Surgery

(10 Plenary Forums - 1Event) Toronto, Canada
September 18-19, 2017

13th Euro Obesity and Endocrinology Congress

Zurich, Switzerland
Oct 23-24, 2017

14th Global Obesity Meeting

Dubai, UAE
October 30- 31, 2017

15th International Conference on Obesity Medicine

Thailand, Bangkok
August 22-23, 2018

Asia Pacific Gynecology and Obstetrics Congress

Tokyo, Japan

Impact on Neurodegenerative Diseases Conference Speakers

Recommended Sessions

Related Journals

Are you interested in